Orogen Therapeutics focuses on designing novel therapeutics using innovative technologies.
Orogen Therapeutics has raised $12.3M in total funding. The most recent round was Series A. The last funding was announced in June 2023.
Orogen Therapeutics's investors include Anterra Capital, Novalis.
Orogen Therapeutics is headquartered in Woburn, United States.
Orogen Therapeutics focuses on designing novel therapeutics using innovative technologies.
Orogen Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orogen Therapeutics — Funding & Investors." VCBacked, June 21, 2023, https://www.vcbacked.co/company/orogen-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Orogen Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/orogen-therapeutics
{{cite web |title=Orogen Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/orogen-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated